US 11530229
Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof
granted A61PA61P35/00A61P37/00
Quick answer
US patent 11530229 (Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof) held by NURIX THERAPEUTICS, INC. expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- NURIX THERAPEUTICS, INC.
- Grant date
- Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 71
- CPC classes
- A61P, A61P35/00, A61P37/00